Transitioning of Herceptin Subsidy to the Pharmaceutical Benefits Scheme (PBS)

Frequently Asked Questions (FAQs) have been prepared that outline the Transitioning of Herceptin Subsidy to the Pharmaceutical Benefits Scheme (PBS).

• FAQ - Transitioning of Herceptin Subsidy to the PBS (PDF KB) - (Word KB)

 

Updated treatment algorithm for the treatment of HER2+ metastatic breast cancer

1 May 2016

The treatment algorithm for anti-HER2 therapies for treating metastatic breast cancer has been updated to reflect recent changes to restrictions for lapatinib and transtuzumab emtansine.

• Updated treatment algorithm for the treatment of HER2+ metastatic breast cancer (PDF 191KB)